Showing results (61-70 of 1,607) with videos related to
Sort By:
Pageof 161
Clinical Therapeutics|July 20, 2010
Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjectsAkiko Sarashina, Shogo Sesoko, Mitsuyoshi Nakashima, et al.Clinical Therapeutics|July 5, 2011
Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor linagliptin: a 4-week multicenter, randomized, double-blind, placebo-controlled phase IIa study in Japanese type 2 diabetes patientsYoshiharu Horie, Shigeto Kanada, Hirotaka Watada, et al.Journal of Clinical Pharmacology|May 22, 2001
Pharmacokinetics and bioavailability of quercetin glycosides in humansE U Graefe, J Wittig, S Mueller, et al.Nursing Times|July 5, 1995
Supporting the patient with inflammatory bowel diseaseS Phillips, J WarrenArtificial Intelligence in Medicine|January 13, 2001
Fuzzy logic for decision support in chronic careG Beliakov, J WarrenJournal of Evolutionary Biology|May 9, 2008
Do flowers wave to attract pollinators? A case study with Silene maritimaJ Warren, P JamesAustralian Family Physician|October 30, 2001
Toward a model for the evaluation of clinical coding systemsP Bolton, J WarrenTopics in Health Information Management|October 30, 2001
Data mining for on-line support of general practiceJ Warren, P BoltonClinical Pharmacology and Therapeutics|April 6, 2007
Pharmacokinetics and pharmacodynamics of the dual FII/FX inhibitor BIBT 986 in endotoxin-induced coagulationJ M Leitner, B Jilma, F B Mayr, et al.Postgraduate Medical Journal|October 12, 2010
Medical leadership: why it's important, what is required, and how we develop itOliver J Warren, Ruth CarnallPageof 161